No Clear Error to Find Lack of Written Description for a Met

No Clear Error to Find Lack of Written Description for a Method of Treatment Patent Despite Separate Disclosures of the Drug, Disease, and Dose (as Part of a Range) | Haug Partners LLP

Biogen International GMBH, Biogen MA, Inc., v. Mylan Pharmaceuticals Inc. marks the Federal Circuit’s most recent interpretation of the 35 U.S.C. § 112 written description requirement...

Related Keywords

West Virginia , United States , , Biogen Ma Inc , District Court Finds Lack Of Written Description , Biogen International , Mylan Pharmaceuticals Inc , Federal Circuit , District Court Finds Lack , Northern District , Broad Specification , Drug Discovery , Not Clinical Efficacy , Related Methods , Doses Included Ineffective , Not Linked , Clinical Data , Multiple Sclerosis , Clinical Efficacy , Therapeutic Efficacy , Judgeo Malley ,